Published in Science on October 11, 1991
The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 9.18
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med (1995) 3.98
IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest (2004) 3.69
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med (1996) 3.41
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest (1993) 3.19
Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest (1993) 3.15
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest (1994) 3.12
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med (1994) 3.02
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev (1996) 2.77
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med (1994) 2.70
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest (1995) 2.66
Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology (1996) 2.65
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med (2005) 2.62
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science (2013) 2.34
T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun (1994) 2.18
CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest (1997) 2.15
Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med (1999) 2.09
Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun (1997) 2.05
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol (2009) 2.00
Constitutive synthesis of tumor necrosis factor in the thymus. Proc Natl Acad Sci U S A (1992) 1.89
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A (2007) 1.75
Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun (1997) 1.74
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med (1994) 1.72
Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J Virol (1996) 1.69
Interleukin-12 in infectious diseases. Clin Microbiol Rev (1997) 1.63
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest (2008) 1.54
Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med (2003) 1.53
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol (1996) 1.52
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med (1993) 1.51
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun (1993) 1.50
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med (1996) 1.49
Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol (2012) 1.49
Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest (1993) 1.47
Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol (2000) 1.44
MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med (2012) 1.43
Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol (1996) 1.40
Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol (1995) 1.40
Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol (1999) 1.39
Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol (1996) 1.37
Detecting cytokine release from single T-cells. Anal Chem (2009) 1.37
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis (2008) 1.34
Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest (1998) 1.33
Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology (2003) 1.31
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci U S A (1992) 1.31
Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest (1997) 1.31
Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses. Infect Immun (1996) 1.27
Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol (1992) 1.22
Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (2000) 1.21
Local expression of antiinflammatory cytokines in cancer. J Clin Invest (1993) 1.21
T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol (1998) 1.20
Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med (1995) 1.18
Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol (1995) 1.18
Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease. Clin Exp Immunol (1995) 1.17
A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae. Infect Immun (1996) 1.17
CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med (1995) 1.16
Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci U S A (1995) 1.16
Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. J Virol (2000) 1.15
NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med (2012) 1.14
An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc Natl Acad Sci U S A (1993) 1.14
Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect Immun (1995) 1.14
Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions. Immunology (1998) 1.14
Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med (1993) 1.10
Generation of rat Th2-like cells in vitro is interleukin-4-dependent and inhibited by interferon-gamma. Immunology (1993) 1.10
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol (2003) 1.10
Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Clin Exp Immunol (1999) 1.10
Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs' heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU). Clin Exp Immunol (1998) 1.09
Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci U S A (1997) 1.08
Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients. Clin Diagn Lab Immunol (1995) 1.08
Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. J Clin Invest (2009) 1.08
Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07
Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury. J Immunol (2008) 1.07
Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus. Infect Immun (1995) 1.07
Cloning, characterization, and antigen specificity of T-lymphocyte subsets extracted from gingival tissue of chronic adult periodontitis patients. Infect Immun (1995) 1.06
Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med (1992) 1.06
Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. J Exp Med (1997) 1.06
T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice. Immunology (1994) 1.05
The functional role of CD8+ T helper type 2 cells. J Exp Med (1995) 1.04
Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol (2004) 1.04
Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. Eur J Clin Microbiol Infect Dis (2009) 1.03
Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect? Cytokine (2007) 1.02
Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins. Infect Immun (1992) 1.02
Prospects for the development of fungal vaccines. Clin Microbiol Rev (1997) 1.02
Bovine CD4(+) T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis. Infect Immun (1999) 1.02
Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol (2001) 1.02
The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med (1994) 1.01
Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol (1994) 1.01
Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation. Clin Exp Immunol (2001) 1.01
Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis. Clin Exp Immunol (2002) 1.01
Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect Immun (1993) 1.01
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. J Clin Invest (1997) 1.01
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74
Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. Br Med J (1972) 7.69
Genetic systems for mycobacteria. Methods Enzymol (1991) 7.50
Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46
Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature (1985) 6.54
Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child (1970) 5.85
Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science (1993) 5.20
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
A new system of dental age assessment. Hum Biol (1973) 5.13
Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature (1995) 5.04
CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci U S A (1988) 4.90
Burden of disease--implications for future research. JAMA (2001) 4.75
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61
Reactions in vivo and in vitro produced by a soluble substance associated with delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1968) 4.57
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis (1983) 4.40
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun (1995) 4.28
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol (1999) 4.10
Smoking in pregnancy and subsequent child development. Br Med J (1973) 4.00
Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol (1999) 3.96
Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. Prog Allergy (1967) 3.86
Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85
Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature (1987) 3.83
Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (1993) 3.80
An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A (1996) 3.78
Retracted Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol (1990) 3.76
Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1997) 3.67
In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun (1995) 3.56
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51
Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli. Nature (1986) 3.51
In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol (1971) 3.49
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun (2000) 3.39
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Mutually dependent secretion of proteins required for mycobacterial virulence. Proc Natl Acad Sci U S A (2005) 3.29
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23
A human T cell-specific molecule is a member of a new gene family. J Immunol (1988) 3.21
Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest (1993) 3.15
Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12
Factors influencing the height of seven year old children--results from the National Child Development Study. Hum Biol (1971) 3.04
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol (1996) 2.98
Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun (1991) 2.77
Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72
Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc Natl Acad Sci U S A (1991) 2.69
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2000) 2.63
Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature (1984) 2.63
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
Studies on the migration inhibitory factor associated with delayed-type hypersensitivity: cytodynamics and specificity. Transplantation (1967) 2.52
Visual acuity and field of vision of urban and rural Egyptians. Public Health Rep (1969) 2.51
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51
An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol (1997) 2.46
Lepromin-induced suppressor cells in patients with leprosy. J Immunol (1979) 2.45
The evolving relation between humans and Mycobacterium tuberculosis. N Engl J Med (1998) 2.39
Three strategies for changing attributions about severe mental illness. Schizophr Bull (2001) 2.39
The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38
Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med (1995) 2.30
Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence. Infect Immun (1989) 2.29
Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27
Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun (1994) 2.26
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A (2000) 2.20
A novel transposon trap for mycobacteria: isolation and characterization of IS1096. J Bacteriol (1991) 2.20
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature (1990) 2.17
Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (1995) 2.17
On the heterogeneity of murine natural killer cells. J Exp Med (1981) 2.15
A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J Exp Med (1970) 2.15
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci U S A (1998) 2.13
High-dose chemotherapy for breast cancer. Ann Intern Med (1996) 2.09
Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clin Pharmacol Ther (1989) 2.08
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07